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Abstract
Purpose—The role of innate immune regulators is investigated in injury sustained from
irradiation as in the clinic for cancer treatment or from a nuclear incident. The protective benefits
of flagellin signaling through Toll-like receptors (TLR) in an irradiation setting warrant study of a
key intracellular adaptor of TLR signaling, namely Myeloid differentiation primary response
factor 88 (MyD88). The role of MyD88 in regulating innate immunity and Nuclear factor kappa-B
(NF-κB)-activated responses targets this critical factor for influencing injury and recovery as well
as maintaining immune homeostasis.
Materials and methods—To examine the role of MyD88, we examined immune cells and
factors during acute pneumonitic and fibrotic phases in Myd88 -deficient animals receiving
thoracic gamma (γ)-irradiation.
Results—We found that MyD88 supports survival from radiation-induced injury through the
regulation of inflammatory factors that aid in recovery from irradiation. The absence of MyD88
resulted in unresolved pulmonary infiltrate and enhanced collagen deposition plus elevated type 2
helper T cell (Th2) cytokines in long-term survivors of irradiation.
Conclusions—These results based only on a gene deletion model suggest that alterations of
MyD88-dependent inflammatory processes impact chronic lung injury. Therefore, MyD88 may
contribute to attenuating long-term radiation-induced lung injury and protecting against fibrosis.
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The lung is a highly radiosensitive organ which represents a prime tissue targeted for
damage due to irradiation (Chen et al. 2002). Direct injury of the endothelial and epithelial
tissues in the lung is a crucial clinical outcome of irradiation, leading to acute pneumonitis
and delayed fibrosis. Radiation pneumonitis is an early response to radiation injury,
resulting from immune and lung parenchymal cell interactions, accompanied by
proinflammatory cytokines and chemokines (Chen et al. 2002, Ao et al. 2009), while fibrosis
is manifested with late lung injury and/or unresolved inflammatory responses. Both cells of
the adaptive immune system, such as thymic-derived lymphocytes (T cells), and of the
innate immune system, such as inflammatory granulocytes or macrophages, have been
implicated in radiation-induced injury (Roberts et al. 1993, Nakayama et al. 1996, Miura et
al. 2000). A role for immune regulation in radiation pneumonitis has been demonstrated by:
(i) The correlation of enhanced proinflammatory cytokines, specifically of Interleukins one
alpha and six (IL-1α and IL-6), with the incidence of radiation pneumonitis (Chen et al.
2002); (ii) the association of prior thymectomy and a lowered incidence of radiation
pneumonitis (McBride and Vegesna 2000); (iii) an increased T cell infiltrate in patients who
later develop radiation pneumonitis compared to those who did not (Roberts et al. 1993,
Nakayama et al. 1996); and (iv) an association of decreased Tumor necrosis factor alpha
(TNFα) caused by treatment with pentoxifylline with ameliorated radiation pneumonitis
(Rube et al. 2002).
Radiation injury is sustained as a consequence of radiotherapy for cancer as well as by
incidental exposure in the case of nuclear accidents or even bioterrorist acts. In either case,
protective measures are important for preventing lethality and for providing amelioration of
off-target effects to non-diseased cells or tissues. Activation of Toll-like receptor (TLR)
signaling, namely toll-like receptor 5 (TLR5) through the exposure to flagellin, has been
reported to be very effective in protecting cells, mice and non-human primates from
radiation-induced lethality (Burdelya et al. 2008, Vijay-Kumar et al. 2008). It is becoming
increasingly important to understand the protective roles supported by TLR signaling in
order to develop immunotherapies that synergize with radio- and chemotherapeutic
approaches for the treatment of cancer patients (Roses et al. 2008).
TLR signaling in mammals has rapidly emerged as a major route by which the immune
system responds to microbial pathogens, pharmacologics, synthetic compounds as well as
non-infectious stress insults through activation and regulation of cell proliferation and
differentiation programs (Medzhitov and Janeway 2000, Akira and Takeda 2004, Beutler
2004, Jiang et al. 2006, McGettrick and O’ Neill 2007). TLR activation requires a host of
intracellular adaptor proteins proximal to the TLR, with the most prominent being Myeloid
differentiation primary response factor 88 (MyD88) (Cao et al. 1996, Hacker et al. 2000,
Wang et al. 2001). With the exception of a subset of toll-like receptors 4 and 3 (TLR4 and
TLR3) stimulations in vivo, all TLR studied to date display MyD88-dependent signaling;
thus an analysis of mice lacking the MyD88 molecule provides a targeted assessment of the
role of TLR signaling in a specific biologic outcome. Although previous human
(Liebermann and Hoffman 2003, Li 2004) and animal studies with Myd88 -null mice have
demonstrated roles of this molecule in atherosclerosis (Bjorkbacka et al. 2004), cancer
adjuvant therapy (Akazawa et al. 2004), onset of autoimmune disorder, and allotransplant
rejection (Goldstein et al. 2003), the in vivo role of MyD88 in radiation-induced pulmonary
injury has not been studied.
Supported by the evidence for roles of adaptive and innate immune responses in radiation-
induced pneumonitis, the focus of this report is to determine the role of MyD88, a specific
key regulator of immunity, in radiation-induced injury. This molecule controls innate
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immunity and proinflammatory responses through its mediation of intracellular signaling
(Kenny and O’ Neill 2008). It is a cytosolic adaptor molecule that acts as an intermediary
between activated TLR, interleukin 1 or 18 receptors (IL-1R/IL-18R) and other signaling
molecules that are proximal to the membrane. MyD88 contains two prominent domains, the
T oll-like receptor/I nterleukin 1 Receptor (TIR) domain and a death domain (Xu et al.
2000). The TIR domain consists of an alpha-beta fold and forms a complex with its
associative membrane receptors (TLR, IL-1R and IL-18R) when the latter become activated
by their respective agonist or ligand. Upon activation, the death domain of MyD88 interacts
with the death domain of IL-1 receptor-associated kinase-1 (IRAK1). This results in the
recruitment of a membrane proximal complex consisting of TNF receptor associated factor 6
(TRAF6), IL-1 receptor-associated kinases-1, 2, or 4 (IRAK1/2/4) and transforming growth
factor-β-activated kinase-1 (TAK-1). Further downstream mediators include nuclear factor-
κ B-inducing kinase (NIK), Inhibitor of nuclear factor-κ B kinase (IKK), Mitogen-activated
protein kinase kinase 1 (MEKK1), and c-jun N-terminal kinase (JNK) that lead to the
endpoint regulators of gene activation, namely nuclear factor-kappaB (NF-κB) and
Mitogen-activated protein kinase (MAPK)-induced activities. NF-κB and MAPK regulate
downstream genes that include an array of cytokines, chemokines, growth factors and cell
surface molecules which can significantly influence innate and adaptive immunity.
The pivotal role MyD88 plays in transmitting intracellular signals from activated innate
immune receptors to the transcriptional regulator NF-κB suggests that elimination of this
gene will significantly alter immune responses to danger, stress or pathogenic stimuli.
Although architectural and physiologic changes in lungs have long been recognized as
adverse events due to radiation exposure, immune mechanisms regulating and/or protecting
against injury are less understood (Abid et al. 2001, Hill 2005, Graves et al. 2010). Here, the
pulmonary consequences of loss of MyD88 to radiation- induced stress have been tested by
treating Myd88 -null animals with a single high dose of gamma (γ)-irradiation to the thorax.
To discern contributions of MyD88 to radiation-induced pulmonary injury and/or repair
during acute and late lung injury phases, the following outcomes were monitored: Survival,
pathology and inflammatory factors (Williams et al. 2010). Mice lacking MyD88 were more
susceptible to death due to thoracic exposure to irradiation and displayed fibrosis hallmarks
such as increased collagen deposition and dysregulated cytokines. Based solely on
examination of gene-deficient mice, these initial results suggest that not only is MyD88
important for homeostasis (Nagai et al. 2006, McGettrick and O’ Neill 2007), but it also
appears to confer a protective role against radiation-induced lung injury. This initial
characterization should pave the way for further study, possibly using cell specific targeting
of MyD88 function as well as biochemical approaches, to identify MyD88 as a critical
molecule for radiation countermeasures.
Materials and methods
Animals
Male mice, aged 8–12 weeks old, were used in these studies. C57BL/6 mice (or wild type,
WT) originally from Jackson Laboratory (Bar Harbor, ME, USA) and bred at The
University of North Carolina at Chapel Hill (UNC-CH), NC, USA along with congenic
Myd88 −/− mice (originally from Dr Shizou Akira, Osaka University, Osaka, Japan)
backcrossed to C57BL/6 mice for at least nine generations from Dr Donald Cook, National
Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, USA
were examined. All animals were housed in an Association for the Assessment and
Accreditation of Laboratory Animal Care accredited pathogen-free facility. All animals were
treated humanely according to National Institutes of Health (NIH) guidelines and procedures
approved by UNC-CH’s Institute of Animal Care and Use Committee.
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Mice received a single dose of thoracic-targeted irradiation (~ 14 gray [Gy]) using a
collimator (Model 335) with a 137Cesium γ-ray source (Model Mark I-68; J.L. Shepherd &
Associates, San Fernando, CA, USA) at a 1.7 Gy/min dose rate. Prior to irradiation, mice
were anesthetized with tribromoethanol (Sigma-Aldrich Corp., St Louis, MO, USA) and
then loosely immobilized over a 2.9 cm2 opening in a lead block (manufactured by UNC-
CH Radiology). The treated mice as well as untreated age-matched controls were housed in
cages in pathogen-free rooms and given standard laboratory chow and water ad libitum.
Routine serological testing of sentinel animals housed alongside the irradiated animals
revealed the absence of mites, pinworms, Mycoplasma pulmonis, and a host of viruses,
including epizootic diarrhea of infant mice (EDIM), Theiler’s murine encephalomyelitis
virus (TMEV GDVII strain), Mouse Hepatitis Virus (MHV), Murine minute virus (MMV),
Murine parvovirus (MPV) and non-structural protein-1 (NS-1) antigen, Pneumonia Virus of
Mice (PVM), and Sendai virus. Experimental and control mice were sacrificed at designated
times up to 27 weeks post irradiation (wpi) for analyses.
Peripheral blood assessment
Hematological tests to determine abundance of lymphocytes, granulocytes and monocytes in
the white blood cell (WBC) fraction on ethylenediaminetetraacetic acid (EDTA)-whole
blood collected by retro-orbital or submandibular bleeding were performed using an Animal
Blood Counter (Heska, Loveland, Colorado, USA) in the Animal Clinical Chemistry
Facility at UNC-CH.
Lung histopathology
Harvested lung tissues were inflated with 10% formalin (Sigma-Aldrich), paraffin-
embedded and sectioned (5 micron) at the Animal Histopathology Core Facility at UNC-
CH. Prepared sections of intact lobe were stained with hematoxylin and eosin (H&E),
Masson’s trichrome (MT) (Sigma-Aldrich) or Picosirius Red (SR) (Polysciences Inc,
Warrington, PA, USA) and viewed by light microscopy (ScanScope microscope, Aperio
Technologies, Vista, CA, USA). Several pathologic features plus degree of cellularity were
assessed by reviewers unaware of the identity of each sample. Each interstitial focal
infiltrate found in the lung section was graded according to the following scale: 0, no
apparent abnormality; 1, cellularity encompassing an area < 25 alveolar spaces; 2, an area
between 25–50 alveolar spaces; 3, an area between 50–100 alveolar spaces; and 4, an area ≥
100 alveolar spaces. The corresponding grades for all the foci per lung sample were
combined to give a cellularity score. Collagen content was determined indirectly by
assessing hydroxyproline levels in the right lung (Smith et al. 1994, Keane et al. 1999) or by
SR staining (Junqueira et al. 1979), where images of seven randomly chosen fields localized
to the subpleural regions were captured using a polarizing filter on a BX61 microscope
(Olympus, Center Valley, PA, USA), with averaged pixels of polarized light determined by
ImageJ analysis (available at NIH via http://rsbweb.nih.gov/ij/). Immunohistochemistry was
performed on deparaffinized and re-hydrated lung tissue sections to examine T cells
(hamster anti-mouse T cell receptor beta or TCRβ antibody conjugated with phycoerythrin,
1:200 dilution, H57-597 clone; Beckman Coulter Incorporated, Miami, FL, USA), and
myeloid cells (rat anti-mouse Integrin alpha M or cell differentiation marker 11b, CD11b,
antibody conjugated with allophycocyanin, 1:200 dilution, M1/70 clone; eBioscience, San
Diego, CA, USA) as described (Arnett et al. 2002, Jha et al. 2010). Sections were mounted
in VECTASHIELD® with 4′, 6-diamidino-2-phenylindole (DAPI) (Vector Laboratories,
Burlingame, CA, USA) and viewed using an Olympus BX-40 microscope fitted with DP72
camera. Images were captured using cellSens® image acquisition software (Olympus) and
immunopositive cells with an observable DAPI-stained nucleus were counted in 5–7
randomly chosen fields per lung section.
Brickey et al. Page 4













Ribonucleic acid (RNA) profiling
Total RNA was generated from lung homogenates using Trizol (Invitrogen Corporation,
Carlsbad, CA, USA), and converted into complementary deoxyribonucleic acid (DNA)
using random hexamers and Moloney Murine Leukemia Virus-Reverse Transcriptase
(MMLV-RT) (Invitrogen), according to manufacturer’s instructions. Then, polymerase
chain reaction (PCR) amplification was performed using gene specific primers with probes
or with cyanine dye (i.e., SYBR green) incorporation using a 7900T Fast Real-Time PCR
System (Applied Biosystems Incorporated or Life Technologies Corporation, Carlsbad, CA,
USA). Primer sequences included: ribosomal RNA (i.e., 18 Svedberg unit, 18S rRNA)
(tetrachlorofluorescin or TET-CAAATTACCCACTCCCGACCCG- black hole quencher or
BH, 5′-GCTGCTGGCACCAGA CTT-3′, 5′-CGGCTACCACATCCAAGG-3′);
Transforming growth factor beta (Tgfb) (6-carboxyfluorescein or
FAMACCTTGGTAACCGGCTGCTGACC -tetramethylrhodamine quencher or TAMRA,
5′-GGAACTCTACCAGAAA TATAGC-3′, 5′-CACTCAGGCGTATCAGTG-3′);
Forkhead box P3 (FoxP3) (FAM-ATCCTACCCACTGCTGGCAAATGGAGTC-TAMRA,
5′-CCCAGGAAAGACAGCAACCTT-3′, 5′-TTCTCACAACCA GGCCACTTG-3′);
Interleukin 1beta (Il1b) (5′-CTCATTGT GGCTGTGGAGAAG-3′, 5′-
ACCAGCAGGTTATCATCATCAT-3′); Interleukin 6 (Il6) (5′-
TACCATAGCTACCTGGAGTACAT-3 ′, 5 ′-CTGTGACTCCAGCTTATCTGTTA-3 ′).
Commercial primer/probe sets (Life Technologies Corporation) for Chemokine (C-C motif)
ligand 2 or Monocyte chemoattractant protein 1 (Ccl2/Mcp1; Mm00441242_m1);
Chemokine (C-X-C motif) ligand 1 or platelet-derived growth factor-inducible KC protein
(Cxcl1/KC; Mm00433859_m1); Endothelin 1 (Edn1; Mm00438656_m1); Hyaluronan
synthase 2 or 3 (Has2; Mm00515089_m1 or Has3; Mm00515091_m1); Intercellular
adhesion molecule (Icam1; Mm00516023_m1); Matrix metalloproteinase 2 (Mmp2;
Mm00439506_m1); Myeloperoxidase (Mpo; Mm01298424_m1); and extracellular
superoxide dismutase 3 (Sod3; Mm00448831_m1) were utilized. Genespecific transcripts
were first normalized to 18S rRNA transcripts for each sample and then ratios of normalized
RNA in treated samples to untreated controls were generated. Fold change in expression
from untreated samples are reported.
Protein profiling
Serum was prepared from blood taken by cardiac puncture and profiled using the Mouse
Cytokine 20-Plex Panel (Invitrogen). Mean protein ± standard error of the mean (SEM) (pg/
ml) are reported with each group consisting of at least three biological replicates (n = 3–5).
Lung physiology assessments
Physiologic measures of lung function in mice surviving for more than 18 wpi were assessed
as described (Irvin and Bates 2003, Lovgren et al. 2006, Glaab et al. 2007). Briefly, mice
were anesthetized, tracheostomized, and mechanically ventilated using a computer-
controlled small animal ventilator or FlexiVent (SCIREQ Incorporated, Montreal, Quebec,
Canada). Pressure-volume curves were used to determine static compliance (Cst) and
oscillatory mechanics were used to determine tissue elastance (H) of the lungs of treated and
control mice.
Statistics
Student’s t- test and Mann-Whitney test were used to contrast results for WT and M yd88−/−
at similar conditions as indicated by dotted lines, while solid lines represent analysis by one
way analysis of variance (ANOVA) for a single genotype over time. Differences with P
values < 0.05 were considered significant. Kaplan-Meier survival curves were generated
using Prism (GraphPad Software Inc., La Jolla, CA, USA).
Brickey et al. Page 5














Myd88−/− mice are susceptible to death due to radiation-induced lung injury
To begin to define the in vivo role of MyD88 in radiationinduced injury, we followed a
cohort of irradiated Myd88−/− mice over time to determine if loss of MyD88 affected
organism survival to thoracic irradiation. Targeting radiation to the thorax while also
shielding the body necessitated an experimental set-up whereby mice were anesthetized (via
intraperitoneal injection of tribromoethanol) immediately prior to immobilization over a 2.9
cm2 opening in a lead block. Anesthetized mice became alert after radiation exposure in the
same time course irrespective of genotype, suggesting no adversity correlating with genetic
differences. Overall, we inferred a protective role for MyD88 as the absence of MyD88
sensitized mice to die sooner (Figure 1A). More than half of the irradiated Myd88−/− mice
were dead by 28 weeks post irradiation (wpi), and 80% of these mice were dead by the end
of the experiment (33 wpi), while the majority of treated wild type (WT) animals survived
the entire course of the experiment.
Peripheral blood cell composition in WT and Myd88−/− mice prior to and after irradiation
was examined. Although not significantly divergent from WT, a trend of diminished cell
numbers in Myd88−/− mice at baseline was seen (Figure 1B). Dynamic changes in peripheral
blood cell types were followed for six weeks during the acute response. Similar kinetic
profiles were found for WT and Myd88−/− animals, with WBC and lymphocyte counts
dropping precipitously by three days and then recovering to or above baseline levels by 6
wpi (Figure 1C). Although granulocytes and monocytes comprised a smaller portion of the
peripheral WBC in absolute numbers, these cell types were relatively static near baseline
levels throughout six weeks following irradiation for WT and M yd88−/− mice, with minor
differences in monocytes at 1.4 weeks and granulocytes prior to radiation in M yd88−/−
mice.
Increased cellularity is evident in the lungs of treated Myd88−/− mice during acute injury
To examine the injury phenotype in the absence of MyD88, we investigated pulmonary
pathology associated with thoracic irradiation. H&E stained lung tissues from treated mice
during six weeks after irradiation were examined for cellular infiltrate (Figure 2A). An
interstitial infiltrate score estimating the number of foci as well as the area of alveolar spaces
spanned by infiltrate was assigned by reviewers unaware of the identity of genotype or time
after treatment. These semi-quantitative observations indicated increased cellularity in lungs
of M yd88−/− mice by 4–6 wpi, whereas WT tissues appeared to have low levels of infiltrate
similar to the basal state (Figure 2B).
To begin to address the nature of the cellular infiltrate, immune cell populations in the lung
were investigated by cell-specific antibody staining of fixed lung sections. T and myeloid
cells were detected by TCRβ and CD11b immunohistochemistry, respectively (Figure 2C).
Examination of these stained sections revealed elevated numbers of TCRβ+ and CD11b+
cells in tissues after irradiation, but with no differences in numbers of immunopositive cells
between WT and Myd88−/− sections (Figure 2D). (Neutrophils, macrophage and other cell
types or activation states were not specifically distinguished.)
Focal damage is evident in long-term surviving radiation-treated Myd88−/− mice
We anticipated that the events occurring during the acute phase of inflammation would
influence the course of repair and long-term pathology (Rubin et al. 1995). Therefore we
examined long term irradiated Myd88−/− and corresponding WT survivors up to 27 weeks
after treatment. Upon histologic examination of fixed lung tissues (Figure 3A), we found
more sites of damage encompassing between 25 and 250 alveolar spaces in long-term
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Myd88−/− survivors from 18–27 wpi. Most of these foci were localized to the sub-pleura. In
contrast, foci in irradiated WT survivors were sparse, appearing between 24 and 27 wpi. The
wet weights of the right lobes of irradiated WT and Myd88−/− mice progressively increased
from 13–27 wpi, with Myd88−/− lungs trending toward greater mass at each respective time
(Figure 3B). Similarly, a dynamic change in body weight, with a loss at 18 wpi, followed by
a rebound increase by 24–27 wpi was evident for WT and Myd88−/− mice with radiation
treatment (Figure 3C).
The link between pulmonary pathology and altered airway function was determined by
assessing respiratory mechanics of unirradiated and treated WT and Myd88−/− mice. Static
lung compliance (Cst), defined as ratio of change in lung volume over change in pressure
under static conditions of zero flow, and tissue elastance (H), an indicator of the degree of
elasticity or rigidity of the lung with forced oscillatory flow, were measured as described
(Lovgren et al. 2006, Glaab et al. 2007). For WT, compliance dropped over the course of
examination from 18–27 wpi (Figure 3D). For M yd88−/− mice, compliance decreased
significantly from 18–24 wpi over unirradiated controls. Examination of the tissue elastance
parameter, essentially the inverse of static compliance, for irradiated WT and Myd88−/−
mice, revealed increasing values, signifying progressively more rigid lungs in response to
forced inflations. Overall, biological parameters observed during the late lung injury phase
for irradiated WT and Myd88−/− mice were very similar, except for the increased incidence
of parenchymal damage localized to the subpleura in lungs of irradiated M yd88−/− mice.
Densely-packed collagen-filled nodules are localized to sub-pleura of lungs of irradiated
Myd88−/− mice
As radiation-induced fibrosis evident in C57BL/6 mice (and related strains) appears to be
heterogeneous (Sharplin and Franko 1989, Dileto and Travis 1996, Chiang et al. 2005,
Jackson et al. 2010, Williams et al. 2010), multiple semi-quantitative approaches were
utilized to examine collagen deposition. These indirect assessments included histological
staining with Masson’s Trichrome (MT) or Picosirius Red (SR) and biochemical analysis of
hydroxyproline content, a surrogate marker of collagen. MT staining revealed that the
nodules observed at low power in H&E stained whole lung lobes in treated Myd88−/− mice
at 24–27 wpi were densely composed of collagen, with similar foci being noticeably
diminished in irradiated WT lung tissue (Figure 4A). SR staining showed collagen
deposition in the sub-pleural foci of lungs of irradiated Myd88−/− mice at 24–27 wpi (Figure
4B), in contrast to minimal sub-pleural localized collagen in irradiated WT mice between 24
and 27 wpi. Consistent with these histological findings, albeit more limited in scope,
biochemical assessment of hydroxyproline content showed that hydroxyproline was
considerably higher in the lungs of long term Myd88−/− survivors at 24 wpi than in
untreated Myd88−/− or WT long-term survivors at 24 wpi (data not shown). Semi-
quantitative evaluation of SR-stained sections using polarized light microscopy indicated
elevated levels of collagen fiber at 27 wpi in Myd88−/− mice in comparison to WT mice at
that time (Figure 4C). Taken together, these results revealed the presence of elevated
collagen associated with a fibrotic phenotype in long term Myd88−/− survivors of
irradiation.
Radiation-induced lung injury in Myd88−/− mice is associated with altered inflammatory,
chemotactic and fibrotic transcriptome responses. We further investigated the immune
potential of the cellular infiltrate by profiling the expression of pro-inflammatory and pro-
fibrogenic factors. Lung tissue from WT and Myd88−/− strains was harvested from mice
during the first six weeks after irradiation and total RNA was isolated. Gene-specific PCR
reagents were used to quantify changes in transcripts in lung tissue.
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The most outstanding changes in expression of inflammatory factors in WT animals due to
radiation stress included inductions of RNA expressing proinflammatory Interleukin-6 (Il6;
10- to 45-fold), Myeloperoxidase (Mpo; 10- to 25-fold), Monocyte chemoattractant protein
1 (Ccl2/Mcp1; ~ 7-fold), and Chemokine (C-X-C motif) ligand 1 (Cxcl1/KC; > 10-fold)
(Figure 5). Increases were most dramatic at 4 wpi, and generally subsided by 6 wpi. In
contrast, the induced expression of Il6, Mpo, Ccl2/Mcp1, and Cxcl1/KC was ameliorated in
irradiated Myd88−/− animals. Likewise, transcripts for extracellular Superoxide dismutase
encoded by Sod3, Transforming growth factor-beta (Tgfb) and Intercellular adhesion
molecule 1 (Icam1) were modestly induced in irradiated WT mice (2- to 3-fold between 10
days and 4 wpi), while these transcripts were only transiently induced by 10 days or not at
all in irradiated Myd88−/− mice. In contrast, the expression of Interleukin-1- beta (Il1b) and
Hyaluronan synthetases 2 and 3 (Has2, Has3) transcripts were elevated (2- to 12-fold,
primarily by 7–10 days after irradiation) in Myd88−/− mice, but not in treated WT mice.
Lastly, transcripts encoding a T cell marker (i.e., Forkhead Box P3 or FoxP3) were similarly
regulated over six weeks between WT and Myd88−/− samples, consistent with the similar
TCRβ immunostaining pattern (Figure 2). Although still a possibility, this observation
suggests that it is less likely that the transcriptional differences found in WT and Myd88−/−
lungs after radiation are due to alterations in cell recruitment to the lung.
Pro-fibrogenic proteins are abundant in long-term Myd88−/− survivors of radiation-
induced lung injury
Lastly, serum from control and treated animals was profiled using a multiplex flow
cytometry approach with antibody-coated microspheres to ascertain the abundance of
inflammatory and fibrogenic proteins. Most notably, levels of effector cytokines
contributing to fibrosis or a type 2 helper T cell (Th2) milieu (i.e., Interleukins IL-5, IL-10,
IL-17) were more abundant in Myd88−/− animals with late lung injury than in similarly aged
and treated WT mice (Figure 6). Also, IL-6 and Macrophage inflammatory protein 1-alpha/
C-C motif chemokine 3 (MIP1α/CCL3) levels in irradiated Myd88−/− mice were
significantly diminished in comparison to WT mice at 18 and 13 wpi, respectively. At 18
wpi, in WT mice, IL-1α, IL-1β and MIP1α levels were lowest, while these factors did not
drop in M yd88−/− mice. There were no significant differences over time or between
genotypes in the levels of MCP1/CCL2, basic Fibroblast growth factor (bFGF), Vascular
endothelial growth factor (VEGF), or IL-2, although a trend of increased IL-2 in Myd88−/−
mice from 13–24 wpi was apparent. Radiation-induced chronic lung injury in Myd88 -
deficient animals appeared to correlate with dysregulated production of immune factors.
Discussion
The critical need to protect host tissue from secondary consequences of irradiation as well as
the current climate of proliferating bioterrorism dangers, whether from irradiation alone or
in combination with pathogenic or other damaging agents, demands the investigation and
application of host defense tools to address how threats may be alleviated and host survival
promoted (DiCarlo et al. 2008). Earlier studies demonstrated that TLR signaling induced by
flagellin plays a protective role for host survival when subjects are treated with irradiation
(Burdelya et al. 2008, Sanders et al. 2008, Vijay-Kumar et al. 2008, Janot et al. 2009).
Notably, TLR signaling has been shown to be induced by a variety of endogenous stimuli,
including heat shock proteins, high mobility group protein B1 (HMGB1), nucleic acids, and
hyaluronan (Jiang et al. 2006), in addition to exogenous agonists or pathogens. There is
strong evidence that MyD88 is a key control element for innate immune signaling in
response to pathogenic stimuli (Skerrett et al. 2004, Rudd et al. 2007, Bretz et al. 2008,
Rahman et al. 2008) as well as mechanical and environmental stresses (Togbe et al. 2006,
Williams et al. 2007, Babcock et al. 2008, Doz et al. 2008). Due to its critical position as
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signaling mediator for host immune responses initiated by TLR, IL-1R, or IL-18R signaling
pathways, MyD88 provides a common fulcrum to examine host defense responses.
Based on this body of work, it was reasonable to expect that MyD88 would play a
significant role in regulating inflammation in the lung, but its role in the repair or
exacerbation of lung injury caused by irradiation exposure had not been previously
described. Therefore, we aimed to broaden the understanding of TLR signaling mediators
and application to the realms of cancer radiotherapy and nuclear bioterrorist threats. In this
study we undertook an investigation of MyD88 in both acute and long-term lung injury
since the lung is exquisitely sensitive to the damaging effects of irradiation (Milano et al.
2007). We found that MyD88 is important for host survival from radiation-induced injury
and that in the absence of MyD88, cells accumulated in the lung, which ultimately displayed
a fibrotic phenotype by 24 weeks following radiation exposure. These results demonstrate
that MyD88 is important for regulating non-infectious inflammatory processes so as to
promote healthy tissue regeneration in the lung after irradiation. In addition to the well-
known role of MyD88 in regulating immune responses to direct and sudden injury, there is
evidence suggesting its role in regulating hematopoeisis and cell replenishment programs
(Nagai et al. 2006, McGettrick and O’ Neill 2007). Since we found some differences in cell
composition, airway physiology and cytokines at basal state in WT and Myd88 -null mice,
further study is required to assess whether the phenotypes are due directly to MyD88
deficiency in the airway or as a consequence of altering the initial basal environment.
These results are consistent with previous reports of injury caused by irradiation of C57BL/6
animals, a strain commonly known to be susceptible to fibrosis, but not to pneumonitis
(Dileto and Travis 1996, Williams et al. 2010). The median survival time of M yd88−/− mice
of 27 wpi occurred just before the 28–30 week mark that has signaled significant respiratory
distress and change in breathing rates and survival in C57BL/6 mice receiving 12–20 Gyγ-
irradiation (Liao et al. 1995, Jackson et al. 2010). For this study, pathology found in lungs of
irradiated C57BL/6 mice was patchy and variable, unlike other reports detailing fibrotic loci
appearing and accumulating between 16–24 weeks post exposure (Chiang et al. 2005) with
the mice recovering with minimal defects. In contrast, collagen-filled foci were localized to
the sub-pleura in irradiated Myd88−/− animals at 18 weeks and increased in density by 27
weeks. Also, proinflammatory factors such as IL-6, CXCL1/KC, and granulocyte colony-
stimulating factor G-CSF have been shown to be hallmarks of inflammation in irradiated
C57BL/6 mice, with a strong correlation between the abundance of each factor in lung and
serum (coefficient of determination, R2, between 0.81 and 0.98) (Ao et al. 2009). In the
absence of MyD88, transcription regulation of Il6, Ccl2/Mcp1 and Cxcl1/KC was
diminished during the initial times post injury and the abundance of these NF-κB-induced
factors was dysregulated during the chronic injury phase. Although other differences in
immediate acute stress responses were not addressed (i.e., thermoregulation and
oxygenation), it seems unlikely that these would predominate over the genetic difference
(i.e., absence of MyD88) that contributes to the chronic inflammatory phenotype found in
Myd88−/− animals.
Although we were surprised initially to see persisting cellular infiltrate and collagen
deposition in the Myd88−/− survivors of radiation lung injury in the context of diminished
abundance of proinflammatory mRNA (i.e., Il6, Ccl2/Mcp1), others have reported
observations of exacerbated lung injury and inflammatory cell accumulation in Myd88−/−
mice due to infection with pulmonary-specific pathogens, Pseudomonas aeruginosa (Skerrett
et al. 2004) or Aspergillus fumigatus (Bretz et al. 2008). Other investigators have described
exacerbated lung injury in Myd88−/− animals using the noninfectious treatment of
chemotherapeutic bleomycin (BLM). Intratracheal instillation of BLM, an agent that
damages tissues through oxidant-mediated DNA attack, has been used primarily in animal
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studies (Chua et al. 2005) as a model of idiopathic pulmonary fibrosis. Lung sections from
BLM-treated Myd88−/− mice revealed enhanced injury consisting of accumulation of
inflammatory cells, thickening of interstitial spaces, an increase in total protein in
bronchoalveolar lavage fluid (BALF) and elevated numbers of apoptotic cells (Jiang et al.
2005, Gasse et al. 2007). Likewise, BLM treatment of Tnf -deficient mice resulted in greater
histopathology in the lungs and accumulation of inflammatory cells with no reduction of
collagen deposition from wild type controls (Kuroki et al. 2003). This is significant as TNF
production is dependent on NF-κB activation which is regulated by MyD88-mediated
signaling. Our results support the conclusion that MyD88 activity is important for regulating
inflammation that stimulates tissue repair, thereby protecting the lung against progressive
injury.
The outcomes of BLM injury in Myd88−/− mice nonetheless differ from our study on several
fronts. With irradiation, we found evidence of fibrosis at 24–27 wpi with collagen deposition
and a profile of increased pro-fibrogenic factors and Th2 cytokines in treated Myd88−/−
mice, while BLM treatment of Myd88−/− resulted in less fibrosis and reduced cellular
infiltrate in comparison to treated WT mice (Gasse et al. 2007). In both studies, production
of proinflammatory factors (IL-6, CXCL1/KC, MPO) was reduced. We suggest that the
development of fibrosis in the Myd88 -null mice surviving for 24–27 wpi is due at least in
part from the persisting cellular infiltrate and changes in extracellular matrix perhaps
attributed to activation of the epithelium (Rube et al. 2005, Yang et al. 2007). In fact, the
abundance of Th2 and regulatory proteins (IL-5, IL-10, IL-17, IL-2) in serum of Myd88−/−
mice at 13–27 wpi promotes the development of a fibrogenic program (Westermann et al.
1999), marked by the upregulation of Has2 and Has3 (Li et al. 2000, Bai et al. 2005). These
results are consistent with other studies reporting the biologic correlation of the induction of
Th2 cytokines and chemokines with the development of fibrosis (Belperio et al. 2004, Ma et
al. 2006, Chapoval et al. 2007, Yoshizaki et al. 2010).
This initial whole organism study underscores the important benefits of MyD88 to tissue
recovery from radiation-induced pulmonary injury. We have shown that mice lacking
MyD88 are susceptible to radiation-induced lung injury and fibrosis, mediated through
dysregulated immune responses. Additional studies not detailed here reveal that irradiation
of animals defective in IL-1β regulation (i.e., Pyrin and caspase recruitment domain-
containing or Pycard -null mice) does not result in a chronic fibrotic phenotype, suggesting
that inflammation regulatory pathways contribute differentially to injury repair and/or
maintenance of immune responsiveness to radiation. Further studies should target the
mechanism of protection afforded by MyD88 in order to propel research toward the
development of therapeutics and mitigating agents against the detrimental effects of
radiation.
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MyD88 provides protection against mortality linked to exposure to thoracic targeted γ-
irradiation. (A) Loss of MyD88 produces a strain susceptible to radiation-induced lung
injury. A Kaplan-Meier survival analysis of irradiated Myd88−/− (n = 25) or WT mice (n =
26) is shown. The median survival time (MST) for Myd88−/− is 27.3 weeks post irradiation
(wpi). Comparison of the survival curves using the log rank test (Mantel-Cox) reveals a
significant difference (p < 0.05), with a hazard ratio of 2.237. Peripheral blood cell
composition of white blood cells (WBC), lymphocytes (Ly), monocytes (Mo) and
granulocytes (Gr) in mice at baseline (B) and after radiation (C) is similar between WT and
Myd88−/− mice. Cells in peripheral blood samples were quantified using Heska’s Animal
Blood Counter. The average absolute numbers (in 1000s) are plotted with significant
differences between WT (solid) and Myd88−/− (open) at indicated times shown by dotted
line with error bars indicating SEM for n = 7 per time for each genotype in (C) (*P < 0.05;
u, untreated).
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Cellularity in lungs of irradiated mice is enhanced during acute injury. (A) Representative
images of H&E stained lung sections of WT (left) and Myd88−/− (right) mice, untreated
(unt) and weeks post irradiation (wpi). (Original magnification 200×) (B) The interstitial
infiltrate of alveolar spaces in unirradiated (u) WT (circle) and Myd88−/− (square) mice and
at 4–6 wpi was scored by reviewers unaware of tissue identity. Individual samples are
represented by each symbol with the averaged cumulative score represented by the bar. *P <
0.05 indicates significantly different means between WT and Myd88−/− at 6 wpi (dotted
line) and for Myd88−/− over time (solid line). (C) Immunohistochemical analysis of lungs
revealed elevated numbers of T lymphocytic (TCRβ+) and myeloid (CD11b+) cells in lungs
of irradiated animals at 6 weeks. Representative images are shown. (Original magnification
200×, scale bar 100 micron) (D) Numbers of antibody-positive DAPI-stained cells were
counted in 5–7 fields for each biological sample, with average CD11b+ or TCRβ+ cells/field
per sample indicated by symbol and mean for each time plotted for untreated (u) samples
and from 1.4–6 wpi.
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Late lung injury persists in irradiated Myd88−/− animals. (A) Fixed lung sections were
stained with H&E and representative images are shown for untreated (unt) and samples from
mice at 18–27 wpi. (Original magnification 40×). Foci of parenchymal damage are marked
with dotted lines. Changes in lung wet weight (B) and body weight (C) were monitored. (D)
Irradiated Myd88−/− mice display impaired airway mechanics. The static compliance (Cst)
and tissue elastance (H) properties were determined through pressure-volume loops and
forced oscillatory mechanics. Each data point in B–D represents an individual animal (WT,
solid circle; Myd88−/−, open square). The mean for each parameter is represented by a bar,
with significant differences over time indicated by the solid bar and between genotypes at
designated times by the dotted bar (*P < 0.05; **P < 0.005; ***P < 0.0005).
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Lungs in Myd88−/− mice display fibrotic foci of collagen deposition. Fixed lung sections
were stained with H&E (unt), Masson’s Trichrome (A) or Sirius Red (B) and representative
images are shown for long term WT and Myd88−/− radiation survivors (24 and 27 wpi)
(Original magnification 200×, scale bar 100 micron). Myd88−/− survivors show elevated
levels of Sirius Red polarized signal (C) at 27 wpi over baseline and WT at similar times.
The assessment of Sirius red signal was executed by reviewers unaware of the identity of the
tissue section. Each data point represents an individual animal, with the mean indicated by a
bar and significant differences between genotypes at designated times by the dotted bar (*P
< 0.05).
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Regulation of RNA expression of proinflammatory cytokines and chemokines is altered in
irradiated Myd88−/− animals during acute injury. Transcripts encoding proinflammatory
cytokines (Il6, Il1b), chemokines (Ccl2/Mcp1, Cxcl1/KC) as well as cell activation factors
(Mpo, Sod3, Tgfb, Icam1, Foxp3, Has2, Has3) were measured using gene-specific primers
and quantitative PCR approaches. Mean fold change over untreated samples of transcript
levels normalized to 18S rRNA are shown with error bars indicating SEM for n = 3–6 for
each group. Changes in transcript levels in Myd88−/− lung samples (open square) that are
significantly different from WT samples (solid circle) are indicated (*P < 0.05; **P < 0.005;
***P < 0.0005).
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Fibrosis-inducing and inflammation-suppressing cytokine levels in irradiated Myd88−/−
mice are elevated in serum. Proteins found in serum from WT (solid) or Myd88−/− (open)
mice either without (u) or with irradiation (13–27 wpi) were characterized using a multiplex
protein immune assay. The mean protein levels (pg/ml) are reported with error bars
indicating SEM for n = 3–5 for each group, and differences between WT and Myd88−/−
samples are indicated by dotted lines (*P < 0.05; **P < 0.005).
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